What are the major opportunities in the Allogeneic T Cell Therapies market? What are the strategies for the Allogeneic T Cell Therapies market?

For detailed insights on the major opportunities and strategies in the Allogeneic T Cell Therapies market, Read More

How does the Allogeneic T Cell Therapies market relate to the overall economy and other similar markets?

For detailed insights on Allogeneic T Cell Therapies's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Allogeneic T Cell Therapies market growth? SWOT analysis of the Allogeneic T Cell Therapies market.

For detailed insights on the key dynamics influencing the Allogeneic T Cell Therapies market growth and SWOT analysis of the Allogeneic T Cell Therapies industry, Read More

Allogeneic T Cell Therapies Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Allogeneic T Cell Therapies Market Report 2026

Name: Allogeneic T Cell Therapies Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies), By Antigen Type (CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types), By Therapeutics Indications (Cancer, Autoimmune Diseases, Infectious Diseases, Other Therapeutics Indications), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Allogeneic T Cell Therapies Market Overview

• Allogeneic T Cell Therapies market size has reached to $1.26 billion in 2025

• Expected to grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%

• Growth Driver: Increasing Cancer Cases Drive Demand For Innovative Therapies

• Market Trend: Innovative Solutions Enhanced Allogeneic T Cell Therapies Market Growth

• North America was the largest region in 2025.

What Is Covered Under Allogeneic T Cell Therapies Market?

Allogeneic T cell therapies are a type of medical treatment where T cells, a crucial component of the immune system, are obtained from a donor (rather than the patient) and used to target and destroy cancer cells in the recipient. Allogeneic T-cell therapies are primarily used in the treatment of various cancers, particularly those that are difficult to treat with conventional methods.

The main types of allogeneic T cell therapies are chimeric antigen receptor (CAR) T cell therapies and T cell receptor (TCR) therapies. Chimeric antigen receptor (CAR) T-cell therapies are a type of immunotherapy where a patient's T-cells are genetically modified to target and destroy cancer cells. This treatment involves reprogramming T-cells to recognize specific proteins in cancer cells. The antigen types for these therapies include CD19, CD20, EgfrvIII, GD2, CD22, CD30, CD33, Meso, HER1, and others. These therapies are used for therapeutic indications such as cancer, autoimmune diseases, infectious diseases, and more, and are utilized by end users including hospitals, specialty clinics, research institutes, and others.

Allogeneic T Cell Therapies Market Global Report 2026 Market Report bar graph

What Is The Allogeneic T Cell Therapies Market Size and Share 2026?

The allogeneic t cell therapies market size has grown strongly in recent years. It will grow from $1.26 billion in 2025 to $1.38 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to limitations of autologous therapies, early success of car-t treatments, rising cancer prevalence, advancements in immunotherapy research, hospital-based oncology expansion.

What Is The Allogeneic T Cell Therapies Market Growth Forecast?

The allogeneic t cell therapies market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to demand for cost-effective cell therapies, expansion of oncology pipelines, improvements in donor matching, regulatory support for cell therapies, growth in specialty cancer centers. Major trends in the forecast period include shift toward off-the-shelf cell therapies, rising clinical trials in oncology, growing focus on scalable cell manufacturing, increased investment in cell engineering, expansion of specialized treatment centers.

Book your 30 minutes free consultation with our research experts

Global Allogeneic T Cell Therapies Market Segmentation

1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies

2) By Antigen Type: CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types

3) By Therapeutics Indications: Cancer, Autoimmune Diseases, Infectious Diseases, Other Therapeutics Indications

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies

2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies

What Is The Driver Of The Allogeneic T Cell Therapies Market?

The increasing cases of cancer are expected to propel the growth of the allogeneic T cell therapies market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer cases are rising due to factors such as longer lifespans, lifestyle changes, environmental exposures, infections, genetic factors, and changes in reproductive patterns, which collectively contribute to a higher incidence and detection of the disease. Allogeneic T cell therapies are used in cancer patients to target and kill cancer cells by infusing genetically engineered donor T cells that recognize specific tumor antigens. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, there were about 18.1 million cancer survivors in the United States. This figure is projected to rise to 22.5 million by 2032. By 2040, it's expected that the number of new cancer cases each year will reach 29.9 million, with cancer-related deaths estimated to increase to 15.3 million. Therefore, the increasing cases of cancer drive the allogeneic T cell therapies industry.

Key Players In The Global Allogeneic T Cell Therapies Market

Major companies operating in the allogeneic t cell therapies market are Allogene Therapeutics Inc., Cellectis SA, Fate Therapeutics Inc., Poseida Therapeutics Inc., Atara Biotherapeutics Inc., Autolus Therapeutics Plc, Adaptimmune Therapeutics Plc, Immatics NV, Medigene AG, Celyad Oncology SA, Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Sangamo Therapeutics Inc., MaxCyte Inc., Tessa Therapeutics Pte Ltd., Cell Medica Inc., Bellicum Pharmaceuticals Inc., Enlivex Therapeutics Ltd., Sorrento Therapeutics Inc.

Global Allogeneic T Cell Therapies Market Trends and Insights

Major companies operating in the allogeneic T cell therapies market are focusing on developing advanced products, such as gene-edited donor-derived CAR-T and TCR T cell therapies, to gain a competitive edge in the market. Gene-edited donor-derived T cell therapies refer to immune-effector T cells sourced from healthy donors that are genetically manipulated (e.g., knocked-out T cell receptor (TCR) and HLA genes, inserted CAR/TCR constructs, built-in safety switches) to create universal off-the-shelf products that can be manufactured in bulk, cryopreserved, and administered rapidly without patient-specific manufacture. For instance, in January 2024, Allogene Therapeutics, a US-based cell therapy company, announced its 2024 platform vision centred on ALPHA3, the industry’s first pivotal trial of an allogeneic CAR-T programme utilising gene-editing technologies to eliminate graft-versus-host disease (GvHD) risk and allow rapid donor-based delivery. The product features include donor-derived T cells edited to remove endogenous TCR and HLA molecules to reduce host immune rejection and GvHD, a chimeric antigen receptor targeting a tumour antigen enabling prompt anti-cancer activity, and cryopreserved ready-to-infuse format to shorten time to treatment compared to autologous therapies.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Allogeneic T Cell Therapies Market?

In January 2023, AstraZeneca plc, a UK-based pharmaceutical company, acquired Neogene Therapeutics Inc. for an undisclosed amount. This acquisition strengthens AstraZeneca’s oncology capabilities by adding Neogene’s expertise in developing cutting-edge T-cell receptor (TCR) therapies targeting cancer-specific mutations in solid tumors. It further enhances the company’s ability to advance innovative cell-based medicines that improve outcomes for patients with hard-to-treat cancers. Neogene Therapeutics Inc. is a US-based biotechnology company that provides allogeneic T-cell therapies.

Regional Insights

North America was the largest region in the allogeneic T cell therapies market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Allogeneic T Cell Therapies Market?

The allogeneic T cell therapies market includes revenues earned by entities providing services such as allogeneic CAR-t cell therapy, allogeneic TCR-t cell therapy, allogeneic NK or T cell therapy, off-the-shelf allogeneic t cell therapy, allogeneic virus-specific t cell therapy, and universal donor t cell therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Allogeneic T Cell Therapies Market Report 2026?

The allogeneic t cell therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the allogeneic t cell therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Allogeneic T Cell Therapies Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.38 billion
Revenue Forecast In 2035	$1.98 billion
Growth Rate	CAGR of 9.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Antigen Type, Therapeutics Indications, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Allogene Therapeutics Inc., Cellectis SA, Fate Therapeutics Inc., Poseida Therapeutics Inc., Atara Biotherapeutics Inc., Autolus Therapeutics Plc, Adaptimmune Therapeutics Plc, Immatics NV, Medigene AG, Celyad Oncology SA, Bristol-Myers Squibb Company, N
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Allogeneic T Cell Therapies Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Allogeneic T Cell Therapies Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Allogeneic T Cell Therapies Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Allogeneic T Cell Therapies Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Shift Toward Off-The-Shelf Cell Therapies

4.2.2 Rising Clinical Trials In Oncology

4.2.3 Growing Focus On Scalable Cell Manufacturing

4.2.4 Increased Investment In Cell Engineering

4.2.5 Expansion Of Specialized Treatment Centers

5. Allogeneic T Cell Therapies Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Oncology Clinics

5.3 Research Institutes

5.4 Cancer Treatment Centers

5.5 Academic Medical Centers

6. Allogeneic T Cell Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Allogeneic T Cell Therapies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Allogeneic T Cell Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Allogeneic T Cell Therapies Market Size, Comparisons And Growth Rate Analysis

7.3. Global Allogeneic T Cell Therapies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Allogeneic T Cell Therapies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Allogeneic T Cell Therapies Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Allogeneic T Cell Therapies Market Segmentation

9.1. Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies

9.2. Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types

9.3. Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutic Indications

9.4. Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Research Institutes, Other End-Users

9.5. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies

9.6. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies

10. Allogeneic T Cell Therapies Market Regional And Country Analysis

10.1. Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Allogeneic T Cell Therapies Market

11.1. Asia-Pacific Allogeneic T Cell Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Allogeneic T Cell Therapies Market

12.1. China Allogeneic T Cell Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Allogeneic T Cell Therapies Market

13.1. India Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Allogeneic T Cell Therapies Market

14.1. Japan Allogeneic T Cell Therapies Market Overview

14.2. Japan Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Allogeneic T Cell Therapies Market

15.1. Australia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Allogeneic T Cell Therapies Market

16.1. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Allogeneic T Cell Therapies Market

17.1. South Korea Allogeneic T Cell Therapies Market Overview

17.2. South Korea Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Allogeneic T Cell Therapies Market

18.1. Taiwan Allogeneic T Cell Therapies Market Overview

18.2. Taiwan Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Allogeneic T Cell Therapies Market

19.1. South East Asia Allogeneic T Cell Therapies Market Overview

19.2. South East Asia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Allogeneic T Cell Therapies Market

20.1. Western Europe Allogeneic T Cell Therapies Market Overview

20.2. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Allogeneic T Cell Therapies Market

21.1. UK Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Allogeneic T Cell Therapies Market

22.1. Germany Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Allogeneic T Cell Therapies Market

23.1. France Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Allogeneic T Cell Therapies Market

24.1. Italy Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Allogeneic T Cell Therapies Market

25.1. Spain Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Allogeneic T Cell Therapies Market

26.1. Eastern Europe Allogeneic T Cell Therapies Market Overview

26.2. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Allogeneic T Cell Therapies Market

27.1. Russia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Allogeneic T Cell Therapies Market

28.1. North America Allogeneic T Cell Therapies Market Overview

28.2. North America Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Allogeneic T Cell Therapies Market

29.1. USA Allogeneic T Cell Therapies Market Overview

29.2. USA Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Allogeneic T Cell Therapies Market

30.1. Canada Allogeneic T Cell Therapies Market Overview

30.2. Canada Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Allogeneic T Cell Therapies Market

31.1. South America Allogeneic T Cell Therapies Market Overview

31.2. South America Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Allogeneic T Cell Therapies Market

32.1. Brazil Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Allogeneic T Cell Therapies Market

33.1. Middle East Allogeneic T Cell Therapies Market Overview

33.2. Middle East Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Allogeneic T Cell Therapies Market

34.1. Africa Allogeneic T Cell Therapies Market Overview

34.2. Africa Allogeneic T Cell Therapies Market, Segmentation By Product Type, Segmentation By Antigen Type, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Allogeneic T Cell Therapies Market Regulatory and Investment Landscape

36. Allogeneic T Cell Therapies Market Competitive Landscape And Company Profiles

36.1. Allogeneic T Cell Therapies Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Allogeneic T Cell Therapies Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Allogeneic T Cell Therapies Market Company Profiles

36.3.1. Allogene Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Cellectis SA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Fate Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Poseida Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Atara Biotherapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Allogeneic T Cell Therapies Market Other Major And Innovative Companies

Autolus Therapeutics Plc, Adaptimmune Therapeutics Plc, Immatics NV, Medigene AG, Celyad Oncology SA, Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Sangamo Therapeutics Inc., MaxCyte Inc., Tessa Therapeutics Pte Ltd., Cell Medica Inc., Bellicum Pharmaceuticals Inc., Enlivex Therapeutics Ltd., Sorrento Therapeutics Inc.

38. Global Allogeneic T Cell Therapies Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Allogeneic T Cell Therapies Market

40. Allogeneic T Cell Therapies Market High Potential Countries, Segments and Strategies

40.1 Allogeneic T Cell Therapies Market In 2030 - Countries Offering Most New Opportunities

40.2 Allogeneic T Cell Therapies Market In 2030 - Segments Offering Most New Opportunities

40.3 Allogeneic T Cell Therapies Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Allogeneic T Cell Therapies Market, Overview Of Key Products - Product Examples

Table 2: Global Allogeneic T Cell Therapies Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Allogeneic T Cell Therapies Market, Supply Chain Analysis

Table 4: Global Allogeneic T Cell Therapies Market, Major Raw Material Providers

Table 5: Global Allogeneic T Cell Therapies Market, Major Resource Providers

Table 6: Global Allogeneic T Cell Therapies Market, Major Manufacturers (Suppliers)

Table 7: Global Allogeneic T Cell Therapies Market, Major Distributors And Channel Partners

Table 8: Global Allogeneic T Cell Therapies Market, Key Technologies & Future Trends

Table 9: Global Allogeneic T Cell Therapies Market, Major Trends

Table 10: Global Allogeneic T Cell Therapies Market, Major End Users

Table 11: Global Allogeneic T Cell Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Allogeneic T Cell Therapies Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Allogeneic T Cell Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Allogeneic T Cell Therapies Market - TAM, US$ Billion, 2025

Table 15: Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Allogeneic T Cell Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Allogeneic T Cell Therapies Market - Company Scoring Matrix

Table 97: Allogene Therapeutics Inc. Financial Performance

Table 98: Cellectis SA Financial Performance

Table 99: Fate Therapeutics Inc. Financial Performance

Table 100: Poseida Therapeutics Inc. Financial Performance

Table 101: Atara Biotherapeutics Inc. Financial Performance

Table 102: Global Allogeneic T Cell Therapies Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Allogeneic T Cell Therapies Market, Competitive Dashboard

Table 104: Global Allogeneic T Cell Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Allogeneic T Cell Therapies Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 106: Global, Allogeneic T Cell Therapies Market Size Gain ($ Billion), Segmentation By Antigen Type, 2025 – 2030

Table 107: Global, Allogeneic T Cell Therapies Market Size Gain ($ Billion), Segmentation By Therapeutics Indications, 2025 – 2030

List Of Figures

Figure 1: Global Allogeneic T Cell Therapies Market, Overview Of Key Products - Product Examples

Figure 2: Global Allogeneic T Cell Therapies Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Allogeneic T Cell Therapies Market, Supply Chain Analysis

Figure 4: Global Allogeneic T Cell Therapies Market, Major Raw Material Providers

Figure 5: Global Allogeneic T Cell Therapies Market, Major Resource Providers

Figure 6: Global Allogeneic T Cell Therapies Market, Major Manufacturers (Suppliers)

Figure 7: Global Allogeneic T Cell Therapies Market, Major Distributors And Channel Partners

Figure 8: Global Allogeneic T Cell Therapies Market, Key Technologies & Future Trends

Figure 9: Global Allogeneic T Cell Therapies Market, Major Trends

Figure 10: Global Allogeneic T Cell Therapies Market, Major End Users

Figure 11: Global Allogeneic T Cell Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Allogeneic T Cell Therapies Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Allogeneic T Cell Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Allogeneic T Cell Therapies Market - TAM, US$ Billion, 2025

Figure 15: Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Allogeneic T Cell Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Allogeneic T Cell Therapies Market - Company Scoring Matrix

Figure 97: Allogene Therapeutics Inc. Financial Performance

Figure 98: Cellectis SA Financial Performance

Figure 99: Fate Therapeutics Inc. Financial Performance

Figure 100: Poseida Therapeutics Inc. Financial Performance

Figure 101: Atara Biotherapeutics Inc. Financial Performance

Figure 102: Global Allogeneic T Cell Therapies Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Allogeneic T Cell Therapies Market, Competitive Dashboard

Figure 104: Global Allogeneic T Cell Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Allogeneic T Cell Therapies Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 106: Global, Allogeneic T Cell Therapies Market Size Gain ($ Billion), Segmentation By Antigen Type, 2025 – 2030

Figure 107: Global, Allogeneic T Cell Therapies Market Size Gain ($ Billion), Segmentation By Therapeutics Indications, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Cell Therapy Market Report 2026 - Global Outlook – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy ), By Therapy Type (Allogeneic Therapies, ...

Cell Therapy Technologies Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cell Types), By Process (Cell Processing, Cell Preservat...

Soil Amendments Market Report 2026 - Global Outlook – By Soil Type (Clay, Sand, Loam, Silt), By Crop Type (Cereals And Grains, Oilseeds And Pulses, Fruits And Vegetables, Other Crop Types), By Application (Construction A...

Oil And Gas Cloud Applications Market Report 2026 - Global Outlook – By Component (Solutions, Services), By Operation (Upstream, Midstream, Downstream), By Deployment Model (Hybrid, Private, Public) – Market Size, Trends...

Cellular Immunotherapy Market Report 2026 - Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Kill...

Remote Sensing Services Market Report 2026 - Global Outlook – By Type (Aerial Photography And Remote Sensing, Data Acquisition And Analytics), By Platform (Defense, Media And Entertainment, Homeland Security Agencies, Ag...

Brine Concentration Technology (BCT) Market Report 2026 - Global Outlook – By Technology (High Energy Reverse Osmosis, Mechanical Vapor Compression, Closed Circuit Desalination, Vertical Tube Falling Film, Other Technolo...

Frequently Asked Questions

How big is the Allogeneic T Cell Therapies Market?

The Allogeneic T Cell Therapies market was valued at $1.26 billion in 2025, increased to $1.38 billion in 2026, and is projected to reach $1.98 billion by 2030.

What is the Allogeneic T Cell Therapies market growth?

The global Allogeneic T Cell Therapies market is expected to grow at a CAGR of 9.4% from 2026 to 2035 to reach $1.98 billion by 2035.

Who are the key players in Allogeneic T Cell Therapies market?

Some Key Players in the Allogeneic T Cell Therapies market Include, Allogene Therapeutics Inc., Cellectis SA, Fate Therapeutics Inc., Poseida Therapeutics Inc., Atara Biotherapeutics Inc., Autolus Therapeutics Plc, Adaptimmune Therapeutics Plc, Immati

Major trend in this market includes: Innovative Solutions Enhanced Allogeneic T Cell Therapies Market Growth. For further insights on this market. request a sample here

North America was the largest region in the allogeneic T cell therapies market in 2025. The regions covered in the allogeneic t cell therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South Ame

Book your 30 minutes free consultation with our research experts

Contact Us